Inhibrx Biosciences, Inc. (INBX)
123.34
-0.59
(-0.48%)
USD |
NASDAQ |
Aug 28, 16:00
123.34
0.00 (0.00%)
After-Hours: 20:00
Inhibrx Biosciences EPS Diluted (Quarterly) : -2.339 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.339 |
| March 31, 2026 | -2.146 |
| December 31, 2025 | -2.114 |
| September 30, 2025 | -2.278 |
| June 30, 2025 | -1.852 |
| March 31, 2025 | -2.80 |
| December 31, 2024 | -3.306 |
| Date | Value |
|---|---|
| September 30, 2024 | -3.030 |
| June 30, 2024 | 128.35 |
| March 31, 2024 | -5.437 |
| December 31, 2023 | -6.466 |
| September 30, 2023 | -3.578 |
| June 30, 2023 | -3.250 |
| March 31, 2023 | -3.379 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AnaptysBio, Inc. | -1.843 |
| 4D Molecular Therapeutics, Inc. | -1.038 |
| Design Therapeutics, Inc. | -0.3226 |
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.65M |
| Total Expenses (Quarterly) | 36.65M |
| Enterprise Value | 1.871B |
| Earnings Yield | -7.20% |
| Normalized Earnings Yield | -7.197 |